Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Centrient Pharmaceuticals is a global B2B pharmaceutical manufacturer headquartered in the Netherlands, with a history dating back to 1869. According to the website, its core positioning is as a supplier of “foundational medicines,” with products covering antibiotics, next-generation statins, and antifungals. It offers intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms (FDFs) such as tablets and capsules.
The website functions more like a corporate site and partnership gateway than an online trading platform. It focuses on presenting the company’s history, product areas, global manufacturing network, leadership team, compliance governance, and sustainability practices. Centrient operates six manufacturing sites and multiple sales offices across regions including the Netherlands, Spain, India, Mexico, and China. Its regulatory capabilities are a notable strength: the site discloses more than 500 local marketing authorizations and over 100 API dossiers, including DMFs and CEPs, making it suitable for pharmaceutical partners that require global registration support.
The website does not publicly list product prices, MOQs, payment terms, or delivery timelines, which is standard practice in the B2B API and pharmaceutical formulations industry. Procurement typically requires a customized quotation based on product specifications, quality documentation, target registration markets, audit requirements, supply location, and purchasing volume.
Its strengths include deep historical expertise, mature fermentation and enzymatic production technologies, and scaled supply capabilities in areas such as penicillin, amoxicillin, cephalosporins, nystatin, and statin APIs. Its disclosures around AMR antimicrobial resistance, supplier audits, carbon reduction, and ESG are also relatively systematic. The main drawback is that the website provides limited detail on specific SKUs, technical parameters, certificate downloads, and commercial processes, so external visitors need to contact the sales or regulatory team for more information.
Suitable for generic drug companies, supply chain teams at multinational pharmaceutical firms, pharmaceutical distributors, regulatory affairs teams, and public health buyers of foundational medicines. It is not suitable for individual patients, retail pharmacies, or small-scale unqualified purchasers.
Based on the official website, the company has a manufacturing site in China and an office in Beijing, and it provides a Chinese version of its Code of Conduct. The site itself is a standard corporate website and should generally be directly accessible, though actual loading speed may still be affected by cross-border network conditions.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on centrient.com official site.
centrient.com is an Netherlands Companies provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach centrient.com directly.